// App-Quantinova.ai

2448 : Patterns of Individual Tumor Response Testing (ITRT) and Bone Marrow Minimal Residual Disease (MRD) On Day 15 of Therapy in Childhood Precursor-B-Lineage Acute Lymphoblastic Leukemia (ALL): MRD and Ex Vivo Drug Resistance Have Similar Predictive Value of Relapse.

Researchers

Presenter

  • Anna Jaworska-Posadzy

Principal Investigators

  • Malgorzata Kubicka

  • Robert Debski

  • Beata Kurylo-Rafinska

  • Beata Kolodziej

  • Monika Pogorzala

  • Magdalena Piatkowska

  • Krzysztof Czyzewski

  • Mariusz Wysocki

Medical Centers

  • Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz,

Locations

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Desmoglein-3

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Daunorubicin

  • Asparaginase

  • Prednisolone

  • Vincristine

  • Doxorubicin

  • Cytarabine liposomal

  • Etoposide

  • Etoposide phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved